Nutritional, Clinical and Sociodemographic Profiles of Spanish Patients with Amyotrophic Lateral Sclerosis
View abstract on PubMed
Summary
This summary is machine-generated.Amyotrophic lateral sclerosis (ALS) patients in Spain show adequate caloric and protein intake but deficiencies in carbohydrates and certain vitamins. Dietary modifications are recommended for better health outcomes.
Area Of Science
- Neurology
- Nutritional Science
- Public Health
Background
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease impacting motor neurons.
- Dietary intake is hypothesized to affect ALS prognosis and disease progression.
- Understanding the nutritional status of ALS patients is crucial for management.
Purpose Of The Study
- To investigate the nutritional, clinical, and sociodemographic characteristics of ALS patients in Spain.
- To compare nutrient intake with established Dietary Reference Intakes (DRI).
Main Methods
- A cross-sectional descriptive study design was employed.
- Data collection included demographics, clinical history, and anthropometric measurements.
- Nutritional intake was assessed and compared against DRI.
Main Results
- Forty ALS patients (25 males, 15 females) were analyzed.
- Caloric and protein intake were generally adequate.
- Significant deficiencies in carbohydrates, vitamin B8, and iodine were observed.
- Excessive intake of lipids, several B vitamins, vitamin C, vitamin E, sodium, phosphorus, and selenium compared to standards.
Conclusions
- ALS patients in Spain exhibit specific nutritional imbalances, including low carbohydrate and micronutrient intake alongside high lipid and certain mineral/vitamin consumption.
- Clinical factors did not correlate with place of origin or diagnosis time.
- Recommendations include dietary habit modification, reducing ultra-processed foods, and increasing intake of healthy fats and fiber.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

